Dr. Tanios Bekaii-Saab
Mark McNiven, Ph.D., and Tanios Bekaii-Saab, M.D., Mayo Clinic Comprehensive Cancer Center researchers, explain what cancer is, how it develops and why it's challenging to treat.
Research on adagrasib has demonstrated promising clinical activity in patients with gastrointestinal cancers that harbor KRAS G12C mutations.
As coronavirus disease 2019 (COVID-19) challenges health care systems across the United States, it poses an extra challenge for physicians in the field of oncology.[...]